Skin lesions and vancomycin use in a hemodialysis patient

Hemodial Int. 2019 Oct;23(4):E127-E129. doi: 10.1111/hdi.12786. Epub 2019 Oct 3.

Abstract

Vancomycin is a widely used antibiotic in hemodialysis patients. The main complications include renal toxicity and skin lesions. Herein, we report the case of a 29-year-old hemodialysis patient who presented a bullous pruriginous dermatosis after vancomycin treatment. A skin biopsy revealed a linear IgA bullous dermatosis (LABD). This is a rare form of dermatosis and is either idiopathic or more likely vancomycin-induced. Similarities in the molecular structure of vancomycin and epidermal basement membrane glycoproteins could explain the auto-immune response. The overall prognosis after drug discontinuation and dermocorticoid treatment was good.

Keywords: dialysis; skin; toxicity; vancomycin.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Humans
  • Linear IgA Bullous Dermatosis / chemically induced*
  • Male
  • Prognosis
  • Renal Dialysis / adverse effects*
  • Renal Dialysis / methods
  • Vancomycin / adverse effects*

Substances

  • Vancomycin